Skip to main content

Month: June 2022

Mission Acquires Dozen Software to Expand its AWS Software Application Development Services

Amid accelerating demand, the deal extends Mission’s capabilities for architecting and building applications on AWS; Dozen Software CEO Chris Downs is named AppDev Practice Lead LOS ANGELES, June 21, 2022 (GLOBE NEWSWIRE) — Mission Cloud Services, a cloud managed services provider and Amazon Web Services (AWS) Premier Tier Services Partner, today announced the acquisition of Dozen Software, a Nashville-headquartered provider of software application development services. With this acquisition, Dozen Software CEO Chris Downs becomes the AppDev Practice Lead at Mission. Dozen Software has earned an exceptional reputation for applying its engineering acumen and creative design expertise to complex and time-sensitive software application development projects. Its client experience spans all industry verticals and company sizes, from...

Continue reading

Global-e to Acquire Borderfree Cross-Border ecommerce Service from Pitney Bowes

The acquisition is expected to strengthen Global-e’s platform offering for enterprise brands. Global-e and Pitney Bowes will also form a cross-border partnership to offer additional services to ecommerce brands. PETAH-TIKVA, Israel and STAMFORD, Conn., June 21, 2022 (GLOBE NEWSWIRE) —  Global-e (NASDAQ: GLBE) (“Global-e” or the “Company”), the world’s leading cross-border end-to-end platform for brands and retailers, today announced that it has entered into a definitive agreement with Pitney Bowes (NYSE: PBI) to acquire the global shipping and mailing company’s Borderfree cross-border ecommerce solutions business. Borderfree helps retailers enter new global markets by localizing their domestic website in 200+ countries and territories, simplifying compliance and regulations processing. In addition, the companies will begin a strategic...

Continue reading

NextPlay Technologies Reports FY2022 Revenue of $8.2 Million

SUNRISE, FL, June 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —NextPlay Technologies, Inc. (NASDAQ: NXTP), a digital business ecosystem for digital advertisers, consumers, video gamers and travelers, reported results for the fourth quarter and fiscal year 2022 ended February 28, 2022.  Fiscal 2022 Financial Highlights ●        Achieved record annual revenue of $8.2 million, which compares very favorably to no revenue in the last year. ●        Consolidated gross profit totaled $5.9 million, or 71%, of total revenue compared to none in the last year. ●        As of February 28, 2022, and 2021, we had total assets of $99.8 million and $11.5 million, respectively, primarily as a result of the reverse merger and additional acquisitions of Reinhart Interactive TV AG and Zappware N.V. and NextBank International. ●        Cash...

Continue reading

Synlogic to Present at the 2022 HCU Network America, Organic Acidemia Association and Propionic Acidemia Foundation Conference

BETHESDA, Md., June 21, 2022 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, announced it will participate in the HCU Network America, Organic Acidemia Association and Propionic Acidemia Foundation 2022 Conference, in Bethesda, Maryland, June 25-26, 2022. Synlogic has been invited to present a poster to patients and families affected by homocystinuria (HCU) regarding SYNB1353, an investigational oral therapy designed to consume methionine for the potential treatment of HCU.Poster Title: Developing SYNB1353, a Methionine-Consuming Synthetic Biotic for the Treatment of Classic Homocystinuria (HCU) Presenting Author: Mylene Perreault, PhD, Executive Director, Head of Biology...

Continue reading

Ceridian Study Reveals 83% of North Americans Value Workplace Wellness

Millennial and Gen Z populations expect employers to support their financial security and well-being in the new world of work TORONTO and MINNEAPOLIS, June 21, 2022 (GLOBE NEWSWIRE) — Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM) technology, today announced the results of a study revealing 83% of surveyed North Americans wish their employer offered non-health benefits, such as on-demand pay and flexible work arrangements, and – if offered – 82% would feel more loyal to their employers. Increased employee expectations are particularly evident among the millennial and Generation Z populations in North America (between the ages of 18-34), especially as many of them are newer entrants to the workforce. Nearly 9-in-10 of these workers who experienced trouble covering expenses between pay periods...

Continue reading

LGI Homes Introduces New Lineup of Single-Family Homes at Popular San Antonio Community, Luckey Ranch

The Reynard is a charming, two-story home available at Luckey Ranch. The Reynard plan at Luckey Ranch is a brand-new home with a spacious family room, chef-ready kitchen and a host of designer-selected upgrades, all included.New, Move-in Ready Homes are Available at Luckey Ranch, Priced from the $280s SAN ANTONIO, Texas, June 21, 2022 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the company is now selling a brand-new collection of single-family homes within the highly sought-after San Antonio community, Luckey Ranch. This new collection of homes at Luckey Ranch range in size from 1,356 square feet with three bedrooms and two-and-a-half bathrooms, to just over 2,100 square feet with four bedrooms and three bathrooms. Designed for more life, these new homes have been carefully crafted with today’s modern homebuyer...

Continue reading

TILT Holdings Partners with Last Prisoner Project to Support Restorative Cannabis Justice

TILT to collaborate with leading non-profit focused on clemency, expungement and successful re-entries for individuals incarcerated for cannabis offenses. PHOENIX, June 21, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a partnership with Last Prisoner Project, a nonprofit organization dedicated to facilitating clemency, expungement and successful re-entries for individuals with cannabis convictions. As part of the agreement that will roll out throughout the year, TILT and Last Prisoner Project will build strategic initiatives that engage across all subsidiaries—Commonwealth Alternative Care, Standard Farms...

Continue reading

ADMA Biologics Announces Addition to the Russell 2000® Index

Ramsey, N.J. and Boca Raton, Fla., June 21, 2022 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the Company will be added to the Russell 2000® Index, effective as of market open on June 27, 2022, according to a preliminary list of additions posted by FTSE Russell on June 17, 2022. The Russell 2000® Index measures the performance of the small-cap segment of the U.S. equity market. Membership in the Russell 2000® Index, which remains in place until the next reconstitution, is based on membership in the broad market Russell 3000® Index. Russell indexes are widely used by investment managers and institutional investors for index funds and...

Continue reading

Theralase® Phase Ib NMIBC Clinical Study Published

TORONTO, June 21, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associated drug formulations intended to safely and effectively destroy various cancers is pleased to announce that Theralase®’s Phase Ib Non-Muscle Invasive Bladder Cancer (“NMIBC”) clinical study (“Study”) has been peer reviewed and published in the European Urology Open Science (“EUOS”) Journal , Volume 41, July 2022. According to EUOS’s website, EUOS is dedicated to the publication of high quality, innovative research that will benefit patients with urological conditions. EUOS covers research in the urological field, including clinical, basic and translational...

Continue reading

Else Nutrition Signs an Agreement to Sell Its Products With buybuy BABY, the Leading Specialty Baby Products Retailer in North America

Else’s expansion into the retailer’s 133 stores in the summer of 2022 expects to boost its national presence and reach millions of new shoppers VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) announces that its Plant-Based complete Nutrition products for babies, toddlers, and kids will soon be available at over 130 locations of buybuy BABY – the leading specialty retailer of baby products in North America. “The expansion into buybuy BABY marks another major milestone for the Company,” said Hamutal Yitzhak, CEO, and Co-Founder of Else Nutrition. “This makes our Complete, Clean Label, Plant-Based Nutrition products for early childhood accessible to millions more wanting shoppers, in North America’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.